# Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy

> **NCT03171493** · PHASE1 · COMPLETED · sponsor: **Vyriad, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **BIOLOGICAL:** MV-NIS

## Key facts

- **NCT ID:** NCT03171493
- **Lead sponsor:** Vyriad, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-20
- **Primary completion:** 2021-02-11
- **Final completion:** 2023-05-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03171493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03171493, "Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03171493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*